DSM Launches New 3C Technology to Reinvigorate Omega-3 Supplements Category
October 03, 2016 at 08:00 am EDT
Share
DSM is launching a new process technology at 2016's Supply Side West (SSW) trade show in Las Vegas on October 6, 2016. The unique 3C technology delivers highly-concentrated (up to 85%) and customizable combinations of EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) for both pharmaceutical and dietary supplement applications, while providing peace of mind through a consistent supply chain. DSM 3C Technology is a radically efficient process technology that makes high-concentrate omega-3 EPA + DHA more accessible and relevant to consumers to build a brighter future. This technology will be a catalyst for category growth by helping to eliminate key barriers to consumption of omega-3 supplements such as capsule size. In addition, it provides brand owners with the versatility to innovate tailored health-focused products to meet consumer needs across a lifetime.
BNY Mellon Strategic Municipal Bond Fund, Inc. (the Fund) is a diversified closed-end management investment company. The Fund's investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital. The Fund ordinarily invests all of its net assets in municipal obligations that provide income exempt from federal personal income tax, and has adopted a fundamental investment policy to invest, under normal market conditions, at least 80% of its net assets in municipal obligations. The Fund may purchase floating and variable rate obligations, municipal derivatives, such as custodial receipt programs created by financial intermediaries, tender option bonds, and participations in municipal obligations. The Fund invests in various industries, including transportation, education, medical, airport, water, power, utilities and multifamily housing. The Fund's investment adviser is BNY Mellon Investment Adviser, Inc.
BNY MELLON STRATEGIC MUNICIPAL BOND FUND, INC. 
